Home » Topics » BioWorld Science

BioWorld Science
RSS

uniQure generates AAV5 vector FIX variant gene therapy for hemophilia A

May 17, 2019

Deinove eyes start of phase II trial with DNV-3837 for C. difficile infection

May 17, 2019

CDH11 is a predictor of unfavorable prognosis in gastric cancer

May 17, 2019

PEP-Therapy completes GLP toxicity studies for PEP-010

May 17, 2019

FDA accepts Cue's IND for first-in-human trial of CUE-101 for HPV-associated cancers

May 17, 2019

FDA clinical hold lifted from second cohort of ADVM-022 in phase I trial for wet AMD

May 17, 2019

FDA lifts partial clinical hold on phase III AIM2CERV trial of axalimogene filolisbac

May 17, 2019

Small molecule OCX-063 protects against experimental diabetic retinopathy

May 17, 2019

Esteve Pharmaceuticals presents dual CACNA2D1/NET ligands

May 17, 2019

Enrollment open in phase III study of fostamatinib in warm antibody autoimmune hemolytic anemia

May 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 21, 2025.
Makary’s vision for slimmed-down US FDA somewhat reassuring
BioWorld
Nearly three weeks into the job, U.S. FDA Commissioner Marty Makary provided a comprehensive overview of his vision for the much-reduced agency, even as he’s...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...
Ouch! Tariffs hit med tech harder than expected
BioWorld MedTech
First quarter earnings reports from Johnson & Johnson and Abbott Laboratories provided some surprising insights into the likely hit med-tech companies will...